Mumbai Worksite Tobacco Control Study
Studieoversigt
Status
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
Through 6 health education events at the worksites, blue-collar workers (who face dual health risks through their exposures to occupational hazards and their high rates of tobacco use) will gain the knowledge, skills, and social support needed to quit tobacco use.
Simultaneously, management will receive OH and tobacco policy consultations to help build a healthy and safe work environment, where workers' hazardous exposures are reduced.
Undersøgelsestype
Tilmelding (Faktiske)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiesteder
-
-
Maharshtra
-
Navi Mumbai, Maharshtra, Indien
- Healis-Sekhsaria Institute for Public Health
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
- Barn
- Voksen
- Ældre voksen
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- Manufacturing worksites located in the Mumbai, Thane, or Raigad districts of India
- Employ at least 60% production workers/40% administrative staff OR at employ at least 200 production workers on staff. NOTE: We are defining "workers" as anyone who is on the company roster, regardless of whether they're permanent or contractual
- Companies must be autonomous decision-makers and allow us to function at their worksite
- Companies must be willing to provide us with a current employee roster
Exclusion Criteria:
- Employees do not speak English, Hindi, or Marathi
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Forebyggelse
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: Intervention Program
Receives the full Healthy, Safe, and Tobacco-Free Worksites intervention
|
Receives an integrated tobacco control and occupational health (OH) intervention (The Healthy, Safe, and Tobacco-Free Worksites program) aimed at promoting tobacco cessation among workers and supporting the adoption, implementation, and enforcement of tobacco control policies. Through six health education events at the worksites, blue-collar workers (who face dual health risks through their exposures to occupational hazards and their high rates of tobacco use) will gain the knowledge, skills, and social support needed to quit tobacco use. Simultaneously, management will receive OH and tobacco policy consultations to help build a healthy and safe work environment, where workers' hazardous exposures are reduced.
Andre navne:
|
|
Andet: Delayed Intervention Control
Receives abbreviated 2-month delayed intervention designed to provide employees with knowledge and skills to quit tobacco after final data collection time point, as well as one non-tobacco event in between data collection points.
|
Receives abbreviated 2-month delayed intervention designed to provide employees with knowledge and skills to quit tobacco after final data collection time point, as well as one non-tobacco event in between data collection points.
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Tidsramme |
|---|---|
|
Tobacco use cessation
Tidsramme: 6-month post intervention
|
6-month post intervention
|
Sekundære resultatmål
Resultatmål |
Tidsramme |
|---|---|
|
Changes in company tobacco policy
Tidsramme: 6-month post intervention
|
6-month post intervention
|
Samarbejdspartnere og efterforskere
Samarbejdspartnere
Efterforskere
- Ledende efterforsker: Glorian Sorensen, PhD, MPH, Harvard School of Public Health, Dana-Farber Cancer Institute
Publikationer og nyttige links
Datoer for undersøgelser
Studer store datoer
Studiestart
Primær færdiggørelse (Faktiske)
Studieafslutning (Faktiske)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Skøn)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Andre undersøgelses-id-numre
- R01CA140304 (U.S. NIH-bevilling/kontrakt)
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
produkt fremstillet i og eksporteret fra U.S.A.
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Intervention Program
-
Hospital Universitario GetafeAfsluttetSkrøbelighedssyndromSpanien
-
University of SevilleUniversity of Jaén; Loyola University; Gobierno de CantabriaRekrutteringForældreskab | Familiefunktion | Børn/ungdomsjusteringSpanien
-
Fundación Centro Nacional de Investigaciones Cardiovasculares...AfsluttetKardiovaskulær sygdom | Sund livsstilSpanien
-
Universidad de GranadaAfsluttetFølelsesmæssig stress | PræstationsangstSpanien
-
Mayo ClinicNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Rekruttering
-
University of AarhusUniversity of Rwanda; University of Luxembourg; Rwanda Biomedical Centre; Karen... og andre samarbejdspartnereUkendtDiabetes mellitus | Telemedicin | Lokale sundhedsarbejdereRwanda
-
Karolinska InstitutetTilmelding efter invitation
-
Chung Shan Medical UniversityAfsluttetDepressionslidelserTaiwan
-
Evgenia E. PsarrakiAfsluttetStørre depressiv lidelseGrækenland
-
University Hospital, GrenobleRekrutteringLægemiddelresistent epilepsiFrankrig